Crossref
SLC10A3 promotes liver cancer progression via modulation of the TGF‑β signaling pathway
Oncology Letters · 18.11.2026 · 33 (1) · 1-14
DOI: 10.3892/ol.2026.15951 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Letters, online erschienen am 18.11.2026. Verfasst von Ouli Long und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Long, O., Yang, C., Yu, M., & Peng, P. (2026). SLC10A3 promotes liver cancer progression via modulation of the TGF‑β signaling pathway. Oncology Letters, 33(1), 1-14. https://doi.org/10.3892/ol.2026.15951
Vancouver
Long O, Yang C, Yu M, Peng P. SLC10A3 promotes liver cancer progression via modulation of the TGF‑β signaling pathway. Oncology Letters. 2026;33(1):1-14. doi:10.3892/ol.2026.15951
BibTeX
@article{Long2026,
author = {Long, Ouli and Yang, Chunling and Yu, Mengmeng and Peng, Pailan},
title = {SLC10A3 promotes liver cancer progression via modulation of the TGF‑β signaling pathway},
journal = {Oncology Letters},
year = {2026},
volume = {33},
number = {1},
pages = {1--14},
doi = {10.3892/ol.2026.15951}
}
EUVIMED